Нейровизуализация острого ишемического инсульта: современное состояние

За последнее десятилетие отмечается значительное усовершенствование методов нейровизуализации для улучшения ранней диагностики острого инсульта. Компьютерная и магнитно-резонансная томография часто используются при внутримозговом кровоизлиянии или для оценки противопоказаний к тромболизису, чтобы обнаружить локализацию зоны ишемии и оценить время начала инсульта. С наличием быстрых и передовых методов визуализации отмечается растущий интерес к их применению для прогнозирования успеха и исключения рисков специфической терапии.

В данном обзоре рассматриваются существующие методы нейровизуализации при острых инсультах. Чтобы интерпретировать результаты нейровизуализации, важно знать клиническую картину. Кроме того, фактор времени, от момента начала инсульта до коллатерального кровоснабжения, должен быть включен в существующие терапевтические стратегии на основе визуализации.

1. Best AC, Acosta NR, Fraser JE et al. Recognizing False Ischemic Penumbras in CT Brain Perfusion Studies. Radiographics. 2012;32(4):П79-П96.

2. Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous Desmoteplase in Patients with Acute Ischaemic Stroke Selected by MRI Perfusion-Diffusion Weighted Imaging or Perfusion CT (DIAS-2): A Prospective, Randomised, Double-Blind, Placebo-Controlled Study. Lancet Neurol. 2009;8(2):141-150.

3. Ahmed N, Kellert L, Lees KR et al. Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): An Observational Study. JAMA Neurol. 2013;70(7):837-844.

4. de Los Rios la Rosa F, Khoury J, Kissela BM et al. Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke. 2012;43(6):1591-1595.

5. Musuka TD, Wilton SB, Traboulsi M et al. Diagnosis and Management of Acute Ischemic Stroke: Speed is Critical. CMAJ. 2015;187(12):887-893.

6. Hacke W, Donnan G, Fieschi C et al. Association of Outcome with Early Stroke Treatment: Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials. Lancet. 2004;363(9411):768-774.

7. Ferrari J, Knoflach M, Seyfang L et al. Differences in Process Management and In-Hospital Delays in Treatment with iv Thrombolysis. PLoS One. 2013;8(9):e75378.

8. Mohan S, Agarwal M, Pukenas B. Computed Tomography Angiography of the Neurovascular Circulation. Radiol Clin North Am. 2016;54(1):147-162.

9. McVerry F, Liebeskind DS, Muir KW. Systematic Review of Methods for Assessing Leptomeningeal Collateral Flow. AJNR Am J Neuroradiol. 2012;33(3):576-582.

10. Hochberg AR, Young GS. Cerebral Perfusion Imaging. Semin Neurol. 2012;32(4):454-465.

11. Xu S, Wang L, Zhao L. Clinical Application Value of Brain CT Perfusion Imaging in the Treatment of Acute Ischemic Stroke Thrombolytic Therapy. Exp Ther Med. 2019;17(5):3971-3976.

12. Campbell BC, Christensen S, Levi CR et al. Comparison of Computed Tomography Perfusion and Magnetic Resonance Imaging Perfusion-Diffusion Mismatch in Ischemic Stroke. Stroke. 2012;43(10):2648-2653.

13. Burton KR, Dhanoa D, Aviv RI et al. Perfusion CT for Selecting Patients with Acute Ischemic Stroke for Intravenous Thrombolytic Therapy. Radiology. 2015;274(1):103-114.

14. Michel P, Ntaios G, Reichhart M et al. Perfusion-CT Guided Intravenous Thrombolysis in Patients with Unknown-Onset Stroke: A Randomized, Double-Blind, Placebo-Controlled, Pilot Feasibility Trial. Neuroradiology. 2012;54(6):579-588.

15. Федоров М. А., Диомидова В. Н., Мигушкина Л. П. Роль магнитно-резонансной томографии в повышении качества оказания медицинской помощи больным с ишемическим инсультом. Практическая медицина. 2015;6(91):115—118.

16. Meuree C, Maurel P, Ferre JC et al. Patch-Based Super-Resolution of Arterial Spin Labeling Magnetic Resonance Images. Neuroimage. 2019;189:85-94.

17. Hendrikse J, Petersen ET, Golay X. Vascular Disorders: Insights from Arterial Spin Labeling. Neuroimaging Clin N Am. 2012;22(2):259-269,x-xi.

18. Zaharchuk G. Arterial Spin Labeling for Acute Stroke: Practical Considerations. Transl Stroke Res. 2012;3(2):228-235.

19. Griebe M, Fischer E, Kablau M et al. Thrombolysis in Patients with Lacunar Stroke is Safe: An Observational Study. J Neurol. 2014;261(2):405-411.

20. Wintermark M, Sanelli PC, Albers GW et al. Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients: A Joint Statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol. 2013;10(11):828-832.

21. Фокин В. А., Янишевский С. Н., Труфа-нов А. Г МРТ в диагностике ишемического инсульта. СПб.: ЭЛБИ-СПб. 2012. с. 96.

22. Moreau F, Asdaghi N, Modi J et al. Magnetic Resonance Imaging Versus Computed Tomography in Transient Ischemic Attack and Minor Stroke: The More You See the More You Know. Cerebrovasc Dis Extra. 2013;3(1):130-136.

23. Kidwell CS, Wintermark M, De Silva DA et al. Multiparametric MRI and CT Models of Infarct Core and Favorable Penumbral Imaging Patterns in Acute Ischemic Stroke. Stroke. 2013;44(1):73-79.

24. Forster A, Griebe M, Wolf ME et al. How to Identify Stroke Mimics in Patients Eligible for Intravenous Thrombolysis? J Neurol. 2012;259(7):1347-1353.

25. Madai VI, Wood CN, Galinovic I et al. Clinical-Radiological Parameters Improve the Prediction of the Thrombolysis Time Window by Both MRI Signal Intensities and DWI-FLAIR Mismatch. Cerebrovasc Dis. 2016;42(1-2):57-65.

26. Tong E, Hou Q, Fiebach JB et al. The Role of Imaging in Acute Ischemic Stroke. Neurosurg Focus. 2014;36(1):E3.

27. Kawano H, Hirano T, Nakajima M et al. Diffusion-Weighted Magnetic Resonance Imaging May Underestimate Acute Ischemic Lesions: Cautions on Neglecting a Computed Tomography-Diffusion-Weighted Imaging Discrepancy. Stroke. 2013;44(4):1056-1061.

28. Hirano T Searching for Salvageable Brain: The Detection of Ischemic Penumbra Using Various Imaging Modalities? J Stroke Cerebrovasc Dis. 2014;23(5):795-798.

29. Stinear CM, Ward NS. How Useful is Imaging in Predicting Outcomes in Stroke Rehabilitation? Int J Stroke. 2013;8(1):33-37.

30. Campbell BC, Purushotham A, Christensen S et al. The Infarct Core is Well Represented by the Acute Diffusion Lesion: Sustained Reversal is Infrequent. J Cereb Blood Flow Metab. 2012;32(1):50-56.

31. Максимова М. Ю., Домашенко М. А., Кротенкова М. В. и др. Нейровизуализация в оценке показаний для тромболизиса. Труды Национального конгресса «Неотложные состояния в неврологии». 2009:114-115.

32. Kushwaha S, Malik S, Sarraf G et al. Thrombolysis in Recurrent Stroke-Beyond Guidelines: A Case Report. J Stroke Cerebrovasc Dis. 2014;23(8):e407-e408.

33. Davis S, Donnan GA. Time is Penumbra: Imaging, Selection and Outcome. The Johann Jacob Wepfer Award 2014. Cerebrovasc Dis. 2014;38(1):59-72.

34. Deprez N, De Herdt V, Vandersteene J et al. Delayed Intravenous Thrombolysis Based on MRI Mismatch in Posterior Circulation Stroke. Acta Neurol Belg. 2014;114(2):113-115.

35. Tisserand M, Naggara O, Legrand L et al. Patient “Candidate” for Thrombolysis: MRI is Essential. Diagn Interv Imaging. 2014;95(12):1135-1144.

36. Albers GW, Thijs Vn, Wechsler L et al. Magnetic Resonance Imaging Profiles Predict Clinical Response to Early Reperfusion: The Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Ann Neurol. 2006;60(5):508-517.

37. Davis SM, Donnan GA, Parsons MW et al. Effects of Alteplase Beyond 3 h After Stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A Placebo-Controlled Randomised Trial. Lancet Neurol. 2008;7(4):299-309.

38. Dani KA, Thomas RG, Chappell FM et al. Computed Tomography and Magnetic Resonance Perfusion Imaging in Ischemic Stroke: Definitions and Thresholds. Ann Neurol. 2011;70(3):384-401.

39. Bivard A, Krishnamurthy V, Stanwell P et al. Arterial Spin Labeling Versus Bolus-Tracking Perfusion in Hyperacute Stroke. Stroke. 2014;45(1):127-133.

40. Mlynash M, Lansberg mG, De Silva DA et al. Refining the Definition of the Malignant Profile: Insights from the DEFUSE-EPITHET Pooled Data Set. Stroke. 2011;42(5):1270-1275.

41. Lansberg MG, Straka M, Kemp S et al. MRI Profile and Response to Endovascular Reperfusion After Stroke (DEFUSE 2): A Prospective Cohort Study. Lancet Neurol. 2012;11(10):860-867.

42. Albers GW, Marks MP, Kemp S et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708-718.

43. Ginsberg MD. The Cerebral Collateral Circulation: Relevance to Pathophysiology and Treatment of Stroke. Neuropharmacology. 2018;134(Pt B):280-292.